Growth Metrics

Gilead Sciences (GILD) Non-Current Assets (2016 - 2026)

Gilead Sciences filings provide 17 years of Non-Current Assets readings, the most recent being $40.7 billion for Q4 2025.

  • On a quarterly basis, Non-Current Assets rose 2.16% to $40.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $161.9 billion, a 0.74% decrease, with the full-year FY2025 number at $40.7 billion, up 2.16% from a year prior.
  • Non-Current Assets hit $40.7 billion in Q4 2025 for Gilead Sciences, roughly flat from $40.7 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $54.2 billion in Q1 2021 to a low of $39.5 billion in Q1 2025.
  • Median Non-Current Assets over the past 5 years was $47.2 billion (2023), compared with a mean of $46.3 billion.
  • Biggest five-year swings in Non-Current Assets: soared 77.31% in 2021 and later fell 14.33% in 2024.
  • Gilead Sciences' Non-Current Assets stood at $53.2 billion in 2021, then decreased by 8.37% to $48.7 billion in 2022, then dropped by 5.52% to $46.0 billion in 2023, then dropped by 13.51% to $39.8 billion in 2024, then rose by 2.16% to $40.7 billion in 2025.
  • The last three reported values for Non-Current Assets were $40.7 billion (Q4 2025), $40.7 billion (Q3 2025), and $41.0 billion (Q2 2025) per Business Quant data.